Skip to main content

Table 2 Diagnosis, admission to hospital/ICU, treatment and death

From: Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study

 

Total number of patients

N = 231

Patients admitted to hospital

N = 115

Patients non-admitted to hospital

N = 116

 

Survivors

N = 67

Non-survivors

N = 48

Survivors

N = 109

Non-survivors

N = 7

Hypoxia, n(%)

102 (44.2)

39 (58.2)

45 (93.8)

12 (11)

7 (100)

Pneumonia, n(%)

123 (53.2)

48 (71.6)

44 (91.6)

25 (22.9)

7 (100)

Hypotension during dialysis, n(%)

67 (29)

20 (29.8)

30 (62.5)

12 (11)

5 (71.4)

Admission to ICU, n(%)

46 (19.9)

12 (17.9)

34 (70.8)

0

0

Intubation, n(%)

30 (13)

4 (5.9)

26 (54.2)

0

0

Thromboembolic events, n(%)

6 (2.6)

1 (1.5)

4 (8.3)

0

1

Anticoagulation, n(%)

98 (42.4)

44 (65.7)

33 (68.7)

19 (17.4)

2 (28.6)

Corticosteroids, n(%)

106 (45.9)

47 (70.1)

35 (72.9)

21 (19.3)

3 (42.8)

Hydroxychloroquine, n(%)

11 (4.7)

8 (11.9)

1 (2.1)

2 (1.8)

0

Antiviral therapy, n(%)

21 (9.1)

3 (4.5)

13 (27.1)

4 (3.7)

1 (14.3)

  1. Note: ICU intensive care unit